Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Tumor progression and metastasis].

R Kath1, C G Schmidt

  • 1Innere Klinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum, Universitätsklinikum Essen.

Zentralblatt Fur Chirurgie
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Markov-modeling for the administration of platinum analogues and paclitaxel as first-line chemotherapy as well as topotecan and liposomal doxorubicin as second-line chemotherapy with epithelial ovarian carcinoma.

Journal of cancer research and clinical oncology·2007
Same author

Risk of malignancies in patients with insulin-treated diabetes mellitus: results of a population-based trial with 10-year follow-up (JEVIN).

European journal of medical research·2005
Same author

Phase I clinical and pharmacokinetic study of combination chemotherapy with topotecan and ifosfamide in patients with progressive or relapsed solid tumors.

Journal of cancer research and clinical oncology·2002
Same author

Isolated brain metastases as the sole manifestation of a late relapse in breast cancer.

Journal of cancer research and clinical oncology·2002
Same author

Regression of brain metastases from breast carcinoma after chemotherapy with bendamustine.

Journal of cancer research and clinical oncology·2002
Same author

[Bendamustine, vincristine, prednisolone (BOP) in therapy of advanced low-grade non-Hodgkin lymphoma]].

Deutsche medizinische Wochenschrift (1946)·2001
Same journal

[Treatment of Vocal Fold Paralysis].

Zentralblatt fur Chirurgie·2026
Same journal

Zentralblatt fur Chirurgie·2026
Same journal

Predictive Factors for Mediastinal Lymph Node Metastases in Patients with Non-small Cell Lung Cancer, as Detected by Video-assisted Mediastinoscopic Lymphadenectomy.

Zentralblatt fur Chirurgie·2026
Same journal

[Robotic Management of a Bile Leak After Cholecystectomy Caused by an Aberrant Bile Duct of the Hepatic Segments, Using a Combined Biliodigestive Anastomosis Incorporating the Cystic Duct Stump].

Zentralblatt fur Chirurgie·2026
Same journal

[Microvascular Reconstruction of the Laryngotracheal Junction].

Zentralblatt fur Chirurgie·2026
Same journal

[Evaluation of Multimodal Perioperative Care Pathway Supported by a Patient-facing Mobile App in Colorectal Surgery - First Clinical Experience and Patient Satisfaction].

Zentralblatt fur Chirurgie·2026
See all related articles

Cellular heterogeneity hinders metastatic disease treatment. Understanding selection mechanisms in metastasis through cytobiology may advance cancer therapies.

Area of Science:

  • Oncology
  • Cell Biology
  • Cancer Metastasis Research

Context:

  • Metastatic diseases pose significant challenges in cancer therapy.
  • Cellular heterogeneity is a key factor complicating treatment and prevention strategies.
  • Existing therapeutic approaches often fall short due to the adaptability of cancer cells.

Purpose:

  • To investigate the role of cellular heterogeneity in the process of metastasis.
  • To elucidate the selective mechanisms driving the diversity of metastatic cells.
  • To explore how understanding these mechanisms can inform novel cancer treatment strategies.

Summary:

  • The study identifies cellular heterogeneity as a primary obstacle in combating metastatic diseases.
  • Evidence suggests that selection processes are responsible for this cellular variety.

Related Experiment Videos

  • Cytobiological investigations are proposed as a method to understand these selective mechanisms.

    • Impact:

    • Findings could lead to more effective treatments for metastatic cancers.
    • A deeper understanding of metastasis could improve disease prevention.
    • This research may contribute to the development of targeted cancer therapies.